Latest news
Featured
Hikma delivers a solid H1 performance and re-affirms expectations for strong growth in the second half
Press Release, Financial Results
07 August 2025
- Hikma signs an exclusive agreement with DGI Group to bring Claritag® to the MENA region Press Release, Business Development 19 November 2025 Hikma signs an exclusive agreement with DGI Group to bring Claritag® to the MENA region
- Hikma confirms 2025 guidance and updates medium-term growth outlook Press Release, Financial Results 06 November 2025 Hikma confirms 2025 guidance and updates medium-term growth outlook
- Hikma Pharmaceuticals announces the launch of STARJEMZA™ (ustekinumab-hmny) Injection, a biosimilar referencing STELARA® (ustekinumab) Injection Press Release, Product 06 November 2025 Hikma Pharmaceuticals announces the launch of STARJEMZA™ (ustekinumab-hmny) Injection, a biosimilar referencing STELARA® (ustekinumab) Injection
- Hikma and Celltrion strengthen partnership to expand biosimilar access in MENA Press Release, Business Development 06 October 2025 Hikma and Celltrion strengthen partnership to expand biosimilar access in MENA
Related content